Much of the conversation at THT revolved around how use of the device would be handled outside of specialized centers.
11d
MyChesCo on MSNWindtree Therapeutics Highlights Promising Phase 2b Results for IstaroximeWindtree Therapeutics, Inc. (NasdaqCM: WINT) showcased encouraging results from the Phase 2b SEISMiC study of istaroxime, its novel investigational therapy for early cardiogenic shock, at the ...
WARRINGTON, Pa. - Windtree Therapeutics, Inc. (NASDAQ:WINT), a biotechnology firm specializing in the development of therapies for critical diseases and currently valued at $1.44 million market ...
This week's CPI report is expected to be on the hotter side. While that may come as news to some, the market has been preparing for a breakout in inflation across the swaps curve. Inflation ...
The flood of Chinese imports that started hitting America a quarter-century ago radically altered the U.S. economy. It upended manufacturing communities, hurt workers and their families, and sowed ...
It is unclear whether an intra‐aortic balloon pump (IABP) or percutaneous ventricular assist device (Impella) in combination with extracorporeal membrane oxygenation (ECMO) is better. Using the ...
Further studies are warranted to investigate the outcomes according to the cause of the cardiogenic shock, learning curves for Impella use, and readmissions in patients who received the Impella. The ...
Despite the substantial stock slump earlier this week, Nvidia shares were up 0.6% at 125.41 on Friday. The market could remain volatile into this week as analysts weigh the long-term implications ...
Might the DeepSeek shock increase Trump’s determination to contain China? For one thing, Trump can’t be happy that China just stole his White House’s AI thunder. It sure seems like a ...
Photo Credit: The Hildner Family. The Society for Cardiovascular Angiography and Interventions (SCAI) today announced that one of its founding members, Frank J. Hildner, MD, for whom the annual ...
Nvidia experienced a historic $589 billion market value loss, triggered by Chinese startup DeepSeek's AI breakthrough. DeepSeek's affordable R1 AI model, rivaling top Silicon Valley models, raised ...
While the Chinese AI start-up has found innovative ways to reduce infrastructure costs for deploying AI, it's easily replicated by more mature and secure models. Chinese start-up DeepSeek rocked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results